108 related articles for article (PubMed ID: 29431335)
1. Open-label study of ademetionine for the treatment of intrahepatic cholestasis associated with alcoholic liver disease.
Ivashkin VT; Maevskaya MV; Kobalava ZD; Uspenskiy YP; Fominih JA; Rozanov AV; Tolkacheva VV; Sotnikova TI; Alikhanov BA; Gorbacheva IA; Ershova OB; Znakhyrenko AA; Sokolov KA; Sander-Struckmeier S
Minerva Gastroenterol Dietol; 2018 Sep; 64(3):208-219. PubMed ID: 29431335
[TBL] [Abstract][Full Text] [Related]
2. Heptral (ademetionine) in patients with intrahepatic cholestasis in chronic liver disease due to non-alcoholic liver disease: results of a multicentre observational study in India.
Virukalpattigopalratnam MP; Singh T; Ravishankar AC
J Indian Med Assoc; 2013 Dec; 111(12):856-9. PubMed ID: 25154164
[TBL] [Abstract][Full Text] [Related]
3. [A meta-analysis of therapeutic trials with ademetionine in the treatment of intrahepatic cholestasis].
Frezza M
Ann Ital Med Int; 1993 Oct; 8 Suppl():48S-51S. PubMed ID: 8117521
[TBL] [Abstract][Full Text] [Related]
4. Oral S-adenosylmethionine in the symptomatic treatment of intrahepatic cholestasis. A double-blind, placebo-controlled study.
Frezza M; Surrenti C; Manzillo G; Fiaccadori F; Bortolini M; Di Padova C
Gastroenterology; 1990 Jul; 99(1):211-5. PubMed ID: 2188871
[TBL] [Abstract][Full Text] [Related]
5. [The results of phase III multicenter open randomized controlled study REM-Chol-III-16 in patients with intrahepatic cholestasis syndrome caused by chronic diffuse liver diseases].
Stel'makh VV; Kovalenko AL; Popova VB; Uspenskiy YP; Morozov VG; Belikova TN; Rafalskiy VV; Antonova EA
Ter Arkh; 2021 Dec; 93(12):1470-1476. PubMed ID: 36286675
[TBL] [Abstract][Full Text] [Related]
6. [Efficacy and safety of ademetionine for treatment of drug-induced liver disease in children].
Zhu SS; Dong Y; Gan Y; Tang HM; Xu ZQ; Chen DW; Jia WZ; Wang LM; Zhang HF
Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi; 2010 Apr; 24(2):136-8. PubMed ID: 21110437
[TBL] [Abstract][Full Text] [Related]
7. [A trial of ademetionine in the treatment of intrahepatic biliary stasis viral hepatitis].
Qin B; Guo S; Zhao Y; Zou S; Zhang Q; Wang Z; Zeng W; Zhang D
Zhonghua Gan Zang Bing Za Zhi; 2000 Jun; 8(3):158-60. PubMed ID: 10880165
[TBL] [Abstract][Full Text] [Related]
8. A review of the studies on the clinical use of S-adenosylmethionine (SAMe) for the symptomatic treatment of intrahepatic cholestasis.
Coltorti M; Bortolini M; Di Padova C
Methods Find Exp Clin Pharmacol; 1990; 12(1):69-78. PubMed ID: 2179653
[TBL] [Abstract][Full Text] [Related]
9. [Alcoholic liver disease: possibilities of diagnosis, treatment and rehabilitation in multidisciplinary hospital].
Pavlov AI; Beliakin SA
Voen Med Zh; 2014 Mar; 335(3):39-46. PubMed ID: 25046935
[TBL] [Abstract][Full Text] [Related]
10. [Clinical efficacy of ademetionine "Heptor" in the therapy of alcohol-dependent liver disease].
Tkachenko EI; Uspenskiĭ IuP; Skvortsova TE
Eksp Klin Gastroenterol; 2008; (2):106-12. PubMed ID: 19145875
[No Abstract] [Full Text] [Related]
11. [Comparative evaluation of clinical efficacy of drugs remaxol and ademetionine in patients with acute ethanol poisoning complicated by the toxic damage of the liver].
Shilov VV; Shikalova IA; Batotsyrenov BV; Andrianov AIu; Vasil'ev SA; Loladze AT
Georgian Med News; 2012 Apr; (205):38-43. PubMed ID: 22665730
[TBL] [Abstract][Full Text] [Related]
12. Early treatment efficacy of S-adenosylmethionine in patients with intrahepatic cholestasis: A systematic review.
Noureddin M; Sander-Struckmeier S; Mato JM
World J Hepatol; 2020 Feb; 12(2):46-63. PubMed ID: 32184941
[TBL] [Abstract][Full Text] [Related]
13. [Correction of metabolic disorders during treatment of alcohol-induced liver injuries in patients with acute alcoholic intoxication].
Shilov VV; Shikalova IA; Vasil'ev SA; Batotsyrenov BV; Andrianov AIu
Klin Med (Mosk); 2013; 91(2):45-8. PubMed ID: 23718065
[TBL] [Abstract][Full Text] [Related]
14. Role of S-adenosyl-L-methionine in the treatment of intrahepatic cholestasis.
Almasio P; Bortolini M; Pagliaro L; Coltorti M
Drugs; 1990; 40 Suppl 3():111-23. PubMed ID: 2081476
[TBL] [Abstract][Full Text] [Related]
15. [Protective effect of ademetionine 1, 4-butanedisulfonate on liver injury caused by chemotherapeutic agents].
Tian YM; Dou LP; Yao S; Yao ZL; Zhang QF; Yu L; Jing Y
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2013 Oct; 21(5):1305-8. PubMed ID: 24156455
[TBL] [Abstract][Full Text] [Related]
16. The role of adenosyl-methionine in alcoholic liver disease and intrahepatic cholestasis.
Testino G; Leone S; Fagoonee S; Pellicano R
Minerva Gastroenterol Dietol; 2018 Sep; 64(3):187-189. PubMed ID: 29521488
[No Abstract] [Full Text] [Related]
17. [Hepato- and endothelioprotective action of runihol and ademetionine in experimental liver injury induced by TB drugs in combination with alcohol].
Sukhanov DS; Artyushkova EB; Dudka VT
Patol Fiziol Eksp Ter; 2013; (2):45-9. PubMed ID: 24000714
[TBL] [Abstract][Full Text] [Related]
18. [Clinical trial of heptral in patients with chronic diffuse liver disease with intrahepatic cholestasis syndrome].
Podymova SD; Nadinskaia MIu
Klin Med (Mosk); 1998; 76(10):45-8. PubMed ID: 9865018
[TBL] [Abstract][Full Text] [Related]
19. Safety and Effectiveness of Liv.52 DS in Patients With Varied Hepatic Disorders: An Open-Label, Multi-centre, Phase IV Study.
Shivnitwar SK; Gilada I; Rajkondawar AV; Ojha SK; Katiyar S; Arya N; Babu UV; Kumawat R
Cureus; 2024 May; 16(5):e60898. PubMed ID: 38784689
[TBL] [Abstract][Full Text] [Related]
20. [Diagnosis and treatment of intrahepatic cholestasis in chronic diseases of the liver].
Golovanova EV; Petrakov AV
Ter Arkh; 2011; 83(2):33-9. PubMed ID: 21516847
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
